vs
Side-by-side financial comparison of BALCHEM CORP (BCPC) and UNIVERSAL TECHNICAL INSTITUTE INC (UTI). Click either name above to swap in a different company.
BALCHEM CORP is the larger business by last-quarter revenue ($270.7M vs $220.8M, roughly 1.2× UNIVERSAL TECHNICAL INSTITUTE INC). BALCHEM CORP runs the higher net margin — 14.9% vs 5.8%, a 9.1% gap on every dollar of revenue. On growth, UNIVERSAL TECHNICAL INSTITUTE INC posted the faster year-over-year revenue change (9.6% vs 8.1%). BALCHEM CORP produced more free cash flow last quarter ($33.8M vs $-19.2M). Over the past eight quarters, UNIVERSAL TECHNICAL INSTITUTE INC's revenue compounded faster (9.5% CAGR vs 7.5%).
Balchem Corp is a global specialty chemicals and nutritional ingredients provider that develops, manufactures and distributes application-specific products for human nutrition, animal health, pharmaceutical and industrial end markets, serving customers across North America, Europe and Asia Pacific.
Universal Technical Institute, Inc. (UTI) is a private for-profit system of technical colleges in the United States. It was established in 1965 by Robert Sweet.
BCPC vs UTI — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $270.7M | $220.8M |
| Net Profit | $40.3M | $12.8M |
| Gross Margin | — | — |
| Operating Margin | 20.5% | 7.1% |
| Net Margin | 14.9% | 5.8% |
| Revenue YoY | 8.1% | 9.6% |
| Net Profit YoY | 8.7% | -42.1% |
| EPS (diluted) | $1.25 | $0.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $270.7M | — | ||
| Q4 25 | $263.6M | $220.8M | ||
| Q3 25 | $267.6M | $222.4M | ||
| Q2 25 | $255.5M | $204.3M | ||
| Q1 25 | $250.5M | $207.4M | ||
| Q4 24 | $240.0M | $201.4M | ||
| Q3 24 | $239.9M | $196.4M | ||
| Q2 24 | $234.1M | $177.5M |
| Q1 26 | $40.3M | — | ||
| Q4 25 | $39.2M | $12.8M | ||
| Q3 25 | $40.3M | $18.8M | ||
| Q2 25 | $38.3M | $10.7M | ||
| Q1 25 | $37.1M | $11.4M | ||
| Q4 24 | $33.6M | $22.2M | ||
| Q3 24 | $33.8M | $18.8M | ||
| Q2 24 | $32.1M | $5.0M |
| Q1 26 | — | — | ||
| Q4 25 | 35.6% | — | ||
| Q3 25 | 35.7% | — | ||
| Q2 25 | 36.4% | — | ||
| Q1 25 | 35.2% | — | ||
| Q4 24 | 36.0% | — | ||
| Q3 24 | 35.6% | — | ||
| Q2 24 | 35.5% | — |
| Q1 26 | 20.5% | — | ||
| Q4 25 | 19.8% | 7.1% | ||
| Q3 25 | 20.4% | 11.2% | ||
| Q2 25 | 20.1% | 6.9% | ||
| Q1 25 | 20.4% | 8.1% | ||
| Q4 24 | 19.8% | 13.6% | ||
| Q3 24 | 20.0% | 13.3% | ||
| Q2 24 | 19.6% | 4.2% |
| Q1 26 | 14.9% | — | ||
| Q4 25 | 14.9% | 5.8% | ||
| Q3 25 | 15.1% | 8.4% | ||
| Q2 25 | 15.0% | 5.2% | ||
| Q1 25 | 14.8% | 5.5% | ||
| Q4 24 | 14.0% | 11.0% | ||
| Q3 24 | 14.1% | 9.6% | ||
| Q2 24 | 13.7% | 2.8% |
| Q1 26 | $1.25 | — | ||
| Q4 25 | $1.21 | $0.23 | ||
| Q3 25 | $1.24 | $0.33 | ||
| Q2 25 | $1.17 | $0.19 | ||
| Q1 25 | $1.13 | $0.21 | ||
| Q4 24 | $1.03 | $0.40 | ||
| Q3 24 | $1.03 | $0.35 | ||
| Q2 24 | $0.98 | $0.09 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $72.9M | $162.8M |
| Total DebtLower is stronger | — | $101.4M |
| Stockholders' EquityBook value | $1.3B | $335.9M |
| Total Assets | $1.7B | $834.0M |
| Debt / EquityLower = less leverage | — | 0.30× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $72.9M | — | ||
| Q4 25 | $74.6M | $162.8M | ||
| Q3 25 | $65.1M | $169.1M | ||
| Q2 25 | $65.4M | $70.7M | ||
| Q1 25 | $49.9M | $96.0M | ||
| Q4 24 | $49.5M | $172.0M | ||
| Q3 24 | $73.7M | $161.9M | ||
| Q2 24 | $63.7M | $115.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | $101.4M | ||
| Q3 25 | — | $87.1M | ||
| Q2 25 | — | $73.8M | ||
| Q1 25 | — | $94.4M | ||
| Q4 24 | — | $120.1M | ||
| Q3 24 | — | $125.7M | ||
| Q2 24 | — | $137.3M |
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.3B | $335.9M | ||
| Q3 25 | $1.3B | $328.1M | ||
| Q2 25 | $1.3B | $306.8M | ||
| Q1 25 | $1.2B | $293.9M | ||
| Q4 24 | $1.1B | $280.0M | ||
| Q3 24 | $1.2B | $260.2M | ||
| Q2 24 | $1.1B | $239.4M |
| Q1 26 | $1.7B | — | ||
| Q4 25 | $1.7B | $834.0M | ||
| Q3 25 | $1.7B | $826.1M | ||
| Q2 25 | $1.7B | $740.8M | ||
| Q1 25 | $1.6B | $720.4M | ||
| Q4 24 | $1.6B | $753.8M | ||
| Q3 24 | $1.6B | $744.6M | ||
| Q2 24 | $1.6B | $706.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.30× | ||
| Q3 25 | — | 0.27× | ||
| Q2 25 | — | 0.24× | ||
| Q1 25 | — | 0.32× | ||
| Q4 24 | — | 0.43× | ||
| Q3 24 | — | 0.48× | ||
| Q2 24 | — | 0.57× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $40.1M | $3.1M |
| Free Cash FlowOCF − Capex | $33.8M | $-19.2M |
| FCF MarginFCF / Revenue | 12.5% | -8.7% |
| Capex IntensityCapex / Revenue | 2.3% | 10.1% |
| Cash ConversionOCF / Net Profit | 0.99× | 0.24× |
| TTM Free Cash FlowTrailing 4 quarters | — | $16.6M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $40.1M | — | ||
| Q4 25 | $67.3M | $3.1M | ||
| Q3 25 | $65.6M | $57.1M | ||
| Q2 25 | $47.3M | $18.1M | ||
| Q1 25 | $36.5M | $-789.0K | ||
| Q4 24 | $52.3M | $23.0M | ||
| Q3 24 | $51.3M | $67.5M | ||
| Q2 24 | $45.0M | $10.0M |
| Q1 26 | $33.8M | — | ||
| Q4 25 | — | $-19.2M | ||
| Q3 25 | — | $40.6M | ||
| Q2 25 | — | $6.8M | ||
| Q1 25 | — | $-11.7M | ||
| Q4 24 | — | $19.6M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $3.0M |
| Q1 26 | 12.5% | — | ||
| Q4 25 | — | -8.7% | ||
| Q3 25 | — | 18.3% | ||
| Q2 25 | — | 3.4% | ||
| Q1 25 | — | -5.7% | ||
| Q4 24 | — | 9.7% | ||
| Q3 24 | — | 30.6% | ||
| Q2 24 | — | 1.7% |
| Q1 26 | 2.3% | — | ||
| Q4 25 | — | 10.1% | ||
| Q3 25 | — | 7.4% | ||
| Q2 25 | — | 5.5% | ||
| Q1 25 | — | 5.3% | ||
| Q4 24 | — | 1.7% | ||
| Q3 24 | — | 3.8% | ||
| Q2 24 | — | 4.0% |
| Q1 26 | 0.99× | — | ||
| Q4 25 | 1.72× | 0.24× | ||
| Q3 25 | 1.63× | 3.04× | ||
| Q2 25 | 1.23× | 1.69× | ||
| Q1 25 | 0.98× | -0.07× | ||
| Q4 24 | 1.56× | 1.04× | ||
| Q3 24 | 1.52× | 3.58× | ||
| Q2 24 | 1.40× | 2.01× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BCPC
Segment breakdown not available.
UTI
| UTI | $142.8M | 65% |
| Concorde | $78.0M | 35% |
